公司資料
NeuroSense Therapeutics 股價、新聞與催化劑
- 股票代碼:
- NRSN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Israel and listed in the U
股票表現
0.38 USD (+7.39%)
收盤價
最後更新: 2026年8月21日
28.9M USD
市值
股價為何變動
As of Aug 21, 2026, NRSN closed up 7.39% at $0.3763. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
NeuroSense Therapeutics is a biotechnology company focused on neurodegenerative diseases such as ALS and related conditions. Its story centers on trying to develop therapies for some of the hardest diseases in CNS medicine.
所在地與產業分類
NeuroSense is headquartered in Israel and listed in the U.S. market. It sits in neuroscience biotechnology.
商業模式特徵
The company depends on clinical proof, translational confidence, and capital efficiency while advancing a narrow neurologic pipeline. Investors usually watch early data and strategic developments.
生技產業定位
NeuroSense occupies a high-catalyst neurodegeneration niche within biotech. The stock is highly dependent on whether its programs can show meaningful neurologic benefit.
未來催化劑
- NeuroSense’s catalysts are primeC and its neurodegeneration programs, plus any update that shows the platform can still keep moving. The company still needs human proof.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。